Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)

– Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe – The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin … [Read more…]

MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era

Peer-reviewed study in ACS Biomacromolecules demonstrates modular VHH potency, cross-variant therapeutic activity, and a newly described immune-priming mechanism; MindWalk holds first right to commercialize jointly developed intellectual property AUSTIN, Texas–(BUSINESS WIRE)–$HYFT #ai–MindWalk Holdings Corp. (NASDAQ: HYFT), a bio-native AI company, today announced B Cell Llama™, a platform for the discovery of VHH nanobodies: the single-domain … [Read more…]

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG

DALLAS & NEW YORK & LONDON & TOKYO–(BUSINESS WIRE)–Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position … [Read more…]

Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America

PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–#ClinicalExcellence–Viper Partners, a healthcare-focused advisory firm, is pleased to announce that it served as the exclusive advisor to Vascular Specialists in its strategic partnership with CUC America, a leading healthcare services organization focused on supporting physician-led specialty platforms. Vascular Specialists is a premier vascular care provider dedicated to delivering comprehensive diagnosis … [Read more…]

Smoke Free Sweden: Nicotine Pouch Restrictions Deprive Canadian Women of Best Tool to Quit Smoking

OTTAWA, Ontario–(BUSINESS WIRE)–On International Women’s Day (March 8), Canadian policymakers are being warned that strict controls on oral nicotine pouches are limiting access to an innovation linked to one of the world’s sharpest declines in female smoking. The warning accompanies the release of a new report, Empowerment in a Pouch, documenting how access to tobacco-free … [Read more…]

Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the “Junior Subordinated Notes Offering”). The Junior Subordinated Notes Offering is expected to close on March … [Read more…]

Oasis Urges Shareholders to Oppose Kobayashi Pharma’s Transition to a Company with an Audit and Supervisory Committee at AGM (Securities Code: 4967 JT)

* Although Oasis generally supports the separation of business execution and oversight, Oasis is calling on shareholders to vote AGAINST Kobayashi Pharma transitioning to a Company with an Audit and Supervisory Committee, as Oasis believes it may further entrench the founding family’s control over the Company * Oasis continues to urge all shareholders to vote … [Read more…]

Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights

– Reported positive top-line data from Phase 2a proof-of-concept (POC) trial of EVO301 in atopic dermatitis (AD) – EVO756 on track to report Phase 2b top-line data in chronic spontaneous urticaria (CSU) and AD in 2Q26 and 2H26, respectively – Strengthened balance sheet with $125 million private placement to support additional clinical milestones and extend … [Read more…]

CHG Healthcare Appoints Ema Prince as President of CompHealth’s Permanent Placement Division, Advancing Enterprise Workforce Strategy

Prince’s expertise will advance CHG’s integrated staffing model, pairing immediate locums solutions with long‑term permanent placement strategies MIDVALE, Utah–(BUSINESS WIRE)–CHG Healthcare announces that Ema Prince has been named President of CompHealth’s Permanent Placement Division, reinforcing the company’s enterprise-wide strategy to help healthcare organizations build stable, long‑term clinical workforces in the face of continued physician shortages. … [Read more…]

Greater Good Health Raises Series B to Improve Outcomes and Better Manage Medical Spend

EL SEGUNDO, Calif.–(BUSINESS WIRE)–Greater Good Health, a premier partner to risk-bearing organizations in managing total cost of care, announced today a $20.5 million Series B financing led by Allumia Ventures, along with up to $12.5 million in a venture debt facility from HSBC Innovation Banking. Participation came from new investors DaVita Venture Group and Granite … [Read more…]